Monocyte Activation in HIV/HCV Coinfection Correlates with Cognitive Impairment

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Rempel, Hans ^a   Sun, Bing ^a   Calosing, Cyrus ^a   Abadjian, Linda ^a   Monto, Alexander ^a,b   Pulliam, Lynn ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD38 ANTIGEN; COMPLEMENTARY DNA; HLA DR ANTIGEN; INTERFERON;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MALE; MIXED INFECTION; MONOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ANTIGENS, CD14; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COGNITION DISORDERS; COINFECTION; DEMOGRAPHY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION;

EID: 84874288486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055776     Document Type: Article

References (51)

1. Alter MJ, (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44: S6-9.
2. Anderson KB, Guest JL, Rimland D, (2004) Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 39: 1507-1513.
3. Koziel MJ, Peters MG, (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445-1454.
4. Operskalski EA, Kovacs A, (2011) HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep 8: 12-22.
5. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P, (2011) HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25: 561-575.
6. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, et al. (2005) Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 41: 801-808.
7. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, et al. (2004) Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41: 845-851.
8. Aronow HA, Weston AJ, Pezeshki BB, Lazarus TS, (2008) Effects of coinfection with HIV and hepatitis C virus on the nervous system. AIDS Read 18: 43-48.
9. Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ, (2008) Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis. 27: 11-17.
10. Vivithanaporn P, Nelles K, DeBlock L, Newman SC, Gill MJ, et al. (2012) Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS. J Neurol Sci 312: 45-51.
11. Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL, (2007) Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 117: 3148-3154.
12. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, et al. (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
13. Kovacs A, Al-Harthi L, Christensen S, Mack W, Cohen M, et al. (2008) CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. J Infect Dis 197: 1402-1407.
14. Gonzalez VD, Falconer K, Blom KG, Reichard O, Morn B, et al. (2009) High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment. J Virol 83: 11407-11411.
15. Kottilil S, Yan MY, Reitano KN, Zhang X, Lempicki R, et al. (2009) Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells. Hepatology 50: 34-45.
16. Pulliam L, Sun B, Rempel H, (2004) Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157: 93-98.
17. Rempel H, Sun B, Calosing C, Pillai SK, Pulliam L, (2010) Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS 24: 1415-1423.
18. Sun B, Linda A, Rempel H, Monto A, Pulliam L (2012) Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection. J Acquir Immune Defic Syndr: In press.
19. Sun B, Abadjian L, Rempel H, Calosing C, Rothlind J, et al. (2010) Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection. J Neurovirol 16: 115-124.
20. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
21. Ihaka R, Gentleman R, (1996) R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics 5: 299-314.
22. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
23. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological) 57: 125-133.
24. Rempel H, Calosing C, Sun B, Pulliam L, (2008) Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS ONE 3: e1967.
25. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, et al. (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10: 317-331.
26. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, et al. (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26: 307-319.
27. Heaton RK, Grant I, Butters N, White DA, Kirson D, et al. (1995) The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 231-251.
28. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
29. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, et al. (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3: e2516.
30. Brown JN, Kohler JJ, Coberley CR, Sleasman JW, Goodenow MM, (2008) HIV-1 activates macrophages independent of Toll-like receptors. PLoS One 3: e3664.
31. Tilton JC, Johnson AJ, Luskin MR, Manion MM, Yang J, et al. (2006) Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol 80: 11486-11497.
32. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, et al. (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14: 1077-1087.
33. Stylianou E, Aukrust P, Bendtzen K, Muller F, Froland SS, (2000) Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection. Clin Exp Immunol 119: 479-485.
34. Lempicki RA, Polis MA, Yang J, McLaughlin M, Koratich C, et al. (2006) Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis 193: 1172-1177.
35. Clifford DB, Smurzynski M, Park LS, Yeh TM, Zhao Y, et al. (2009) Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology 73: 309-314.
36. Perry W, Carlson MD, Barakat F, Hilsabeck RC, Schiehser DM, et al. (2005) Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS 19Suppl 3: S79-84.
37. Crystal H, Kleyman I, Anastos K, Lazar J, Cohen M, et al. (2012) Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 59: 149-154.
38. Garvey LJ, Pavese N, Ramlackhansingh A, Thomson E, Allsop JM, et al. (2012) Acute HCV/HIV Coinfection Is Associated with Cognitive Dysfunction and Cerebral Metabolite Disturbance, but Not Increased Microglial Cell Activation. PLoS One 7: e38980.
39. El Yakoubi W, Borday C, Hamdache J, Parain K, Tran HT, et al. (2012) Hes4 Controls Proliferative Properties of Neural Stem Cells During Retinal Ontogenesis. Stem Cells.
40. Kageyama R, Ohtsuka T, Kobayashi T, (2007) The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 134: 1243-1251.
41. Santer DM, Wiedeman AE, Teal TH, Ghosh P, Elkon KB, (2012) Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes. J Immunol 188: 902-915.
42. Pulliam L, Rempel H, Sun B, Abadjian L, Calosing C, et al. (2011) A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations. AIDS 25: 1721-1726.
43. Brenchley JM, Price DA, Douek DC, (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7: 235-239.
44. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, et al. (2008) Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology. 135: 226-233.
45. Moir S, Chun TW, Fauci AS, (2011) Pathogenic mechanisms of HIV disease. Annu Rev Pathol 6: 223-248.
46. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
47. Bower M, Palmieri C, Dhillon T, (2006) AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 19: 14-19.
48. Battegay M, Nuesch R, Hirschel B, Kaufmann GR, (2006) Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 6: 280-287.
49. Steel A, John L, Shamji MH, Henderson DC, Gotch FM, et al. (2008) CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy. HIV Med 9: 118-125.
50. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17: 3-16.
51. Nelson DR, Zeuzem S, Andreone P, Ferenci P, Herring R, et al. (2012) Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients. Ann Hepatol 11: 15-31.